The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Ralley Prentice1,2
- Aysha Al‐Ani3
- Tiffany Cherry3
- Julia Dixon‐Douglas4
- Jade Eccles‐Smith5
- Julia Matheson3
- Jeanne Tie4,6
- Iniyaval Thevathasan5
- Jacob J McCormick3,4
- Britt Christensen3
- 1 Monash Health, Melbourne
- 2 St Vincent’s Hospital Melbourne, Melbourne, VIC
- 3 Royal Melbourne Hospital, Melbourne, VIC
- 4 Peter MacCallum Cancer Centre, Melbourne, VIC
- 5 Royal Women's Hospital, Melbourne, VIC
- 6 University of Melbourne, Melbourne, VIC
Correspondence: ralley.prentice@monashhealth.org.au
Competing interests:
Britt Christensen has received speaking fees from Abbvie, Jannsen, Pfizer, Takeda and Ferring Pharmaceuticals, and research grants from Janssen and Ferring Pharmaceuticals, and has served on the advisory boards of Gilead and Novartis.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Summary